Two Human Phase I Trials ,, The Cancer Trial hit its Primary end point and gained sufficient safety data to proceed to Phase II already..
ANZCTR 2016
Sufficient data was obtained to permit proceeding to Phase II study, i.e. a safe and active dose.
The study was also terminated to permit reformulation of study drug to a more palatable formulation.
Two Human Phase I Trials ,, The Cancer Trial hit its Primary end...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $86.15M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.5¢ | 16.5¢ | $91.76K | 527.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 80407 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 31 | 1 |
View Market Depth
| Last trade - 15.34pm 20/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |